FDA slams former CytoDyn CEO's misleading interview in new warning letter

The FDA’s Office of Prescription Drug Promotion recently sent another harsh warning to tiny biotech company CytoDyn for a promo video in which the company’s recently booted CEO makes unsubstantiated claims about its unauthorized Covid-19 treatment known as leronlimab.